Page 41 - Ovarian Cancer Surgery - Quality Indicators
P. 41
113. Shellenberger, T.D., Madero-Visbal, R. & http://www.albertahealthservices.ca/assets
Weber, R.S. Quality indicators in head and /info/hp/cancer/if-hp-cancer-guide-
neck operations: a comparison with gyne005-epithelialovarian.pdf 2013.
published benchmarks. Arch Otolaryngol
Head Neck Surg 137, 1086-1093 2011. 122. Gonzalez-Martin, A., Bover, I., Del
Campo, J.M., Redondo, A. & Vidal, L.
114. Stang, A.S., Hartling, L., Fera, C., SEOM guideline in ovarian cancer 2014.
Johnson, D. & Ali, S. Quality indicators Clin Transl Oncol 16, 1067-1071 2014.
for the assessment and management of
pain in the emergency department: a 123. Ledermann, J.A., et al. Newly diagnosed
systematic review. Pain Res Manag 19, and relapsed epithelial ovarian carcinoma:
e179-190 2014. ESMO Clinical Practice Guidelines for
diagnosis, treatment and follow-up. Ann
115. Stelfox, H.T. & Straus, S.E. Measuring Oncol 24 Suppl 6, vi24-32 2013.
quality of care: considering measurement
frameworks and needs assessment to guide 124. NICE. Ovarian cancer.
quality indicator development. J Clin
Epidemiol 66, 1320-1327 2013. http://pathways.nice.org.uk/pathways/ovar
116. Verleye, L., et al. Quality of pathology ian-
reports for advanced ovarian cancer: are
we missing essential information? An cancer#path=view%3A/pathways/ovarian-
audit of 479 pathology reports from the
EORTC-GCG 55971/NCIC-CTG OV13 cancer/ovarian-cancer-
neoadjuvant trial. Eur J Cancer 47, 57-64
2011. overview.xml&content=view-index 2014.
117. Webber, C., Siemens, D.R., Brundage, M. 125. NCCN. Ovarian cancer including fallopian
& Groome, P.A. Quality of care indicators tube cancer and primary peritoneal cancer.
and their related outcomes: A population- http://www.nccn.org/professionals/physici
based study in prostate cancer patients an_gls/pdf/ovarian.pdf 2015.
treated with radical prostatectomy. Can
Urol Assoc J 8, E572-579 2014. 126. Gonzalez Martin, A., et al. GEICO
Spanish Group for Investigation on
118. Wagner, U., et al. S3-Guideline on Ovarian Cancer treatment guidelines in
Diagnostics, Therapy and Follow-up of ovarian cancer 2012. Clin Transl Oncol
Malignant Ovarian Tumours: Short 15, 509-525 2013.
version 1.0 - AWMF registration number:
032/035OL, June 2013. Geburtshilfe 127. Elattar, A., Bryant, A., Winter-Roach,
Frauenheilkd 73, 874-889 2013. B.A., Hatem, M. & Naik, R. Optimal
primary surgical treatment for advanced
119. Stuart, G.C., et al. 2010 Gynecologic epithelial ovarian cancer. Cochrane
Cancer InterGroup GCIG con sensus Database Syst Rev, CD007565 2011.
statement on clinical trials in ovarian
cancer: report from the Fourth Ovarian 128. Chang, S.J., Hodeib, M., Chang, J. &
Cancer Consensus Conference. Int J Bristow, R.E. Survival impact of complete
Gynecol Cancer 21, 750-755 2011. cytoreduction to no gross residual disease
for advanced-stage ovarian cancer: a meta-
120. SIGN. Management of epithelial ovarian analysis. Gynecol Oncol 130, 493-498
cancer. 2013.
http://www.sign.ac.uk/pdf/sign135.pdf
2013. 129. Akahira, J.I., et al. Prognostic factors of
stage IV epithelial ovarian cancer: a
121. AHS. Epithelial ovarian, fallopian tube, multicenter retrospective study. Gynecol
and primary peritoneal cancer. Oncol 81, 398-403 2001.
130. Aletti, G.D., et al. Aggressive surgical
effort and improved survival in advanced-
stage ovarian cancer. Obstet Gynecol 107,
77-85 2006.
OVARIAN CANCER SURGERY - QUALITY INDICATORS
41
